PRRT2 and diabetes mellitus: The activation of PKC in the vascular tissues, as occurs in diabetes and insulin resistance, may inhibit PI-3 kinase activity and eNOS expression, likely through the activation of G protein-coupled receptor kinases, which negatively regulate the insulin-mediated Akt/eNos pathway and contribute to oxidative stress [43,44].